statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.066
RU - Federazione Russa	221
SG - Singapore	145
PL - Polonia	136
CN - Cina	92
SE - Svezia	59
HK - Hong Kong	58
IE - Irlanda	57
VN - Vietnam	42
IT - Italia	41
UA - Ucraina	40
DE - Germania	37
BR - Brasile	29
KR - Corea	29
FI - Finlandia	16
FR - Francia	15
GB - Regno Unito	15
AU - Australia	8
IN - India	7
BD - Bangladesh	6
MX - Messico	6
BE - Belgio	5
CA - Canada	5
JO - Giordania	5
TR - Turchia	5
PH - Filippine	4
AR - Argentina	3
CH - Svizzera	3
CI - Costa d'Avorio	3
EC - Ecuador	3
ID - Indonesia	3
IQ - Iraq	3
ES - Italia	2
NL - Olanda	2
PK - Pakistan	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AT - Austria	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BO - Bolivia	1
BZ - Belize	1
DO - Repubblica Dominicana	1
GA - Gabon	1
GY - Guiana	1
IL - Israele	1
JP - Giappone	1
KE - Kenya	1
KH - Cambogia	1
MY - Malesia	1
NO - Norvegia	1
OM - Oman	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
UZ - Uzbekistan	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	2.203

Nome	#
Evidence for oxidative stress in plasma of patients with Marfan syndrome	328
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.	205
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients	198
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS	196
Fibroblast autofluorescence in connective tissue disorders: a future tool for clinical and differential diagnosis?	190
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up.	172
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease.	171
Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: Role of dural ectasia for the diagnosis.	160
FIBRILLIN-1 (FBN1) GENE FRAMESHIFT MUTATIONS IN MARFAN PATIENTS: GENOTYPE-PHENOTYPE CORRELATION	158
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.	154
Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion	152
Marfan's syndrome. Clinical and molecular characterization of 51 italian patients	125
Totale	2.209

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	21	0	0	0	0	0	0	0	0	0	0	6	15
2021/2022	75	4	5	1	3	4	5	1	5	2	6	12	27
2022/2023	299	21	58	12	32	32	45	36	26	27	1	5	4
2023/2024	78	2	9	11	7	3	15	6	19	2	2	0	2
2024/2025	623	19	60	37	100	182	95	5	47	31	8	20	19
2025/2026	507	66	84	44	27	80	27	62	28	38	39	12	0
Totale													2.209